1. Snowden JA, Heaton DC. Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity. Br J Dermatol. 1997; 137:130–132.
Article
2. Adkins DR, Abidi MH, Brown RA, Khoury H, Goodnough LT, Vij R, et al. Resolution of psoriasis after allogeneic bone marrow transplantation for chronic myelogenous leukemia: late complications of therapy. Bone Marrow Transplant. 2000; 26:1239–1241.
Article
3. Ahn HS, Park HJ, Lee JY, Cho BK. A case of chronic cutaneous graft versus host disease with the clinical features of exfoliative dermatitis. Ann Dermatol. 2009; 21:319–322.
Article
4. Masszi T, Farkas A, Remenyi P, Lueff S, Batai A, Krivan G, et al. Ten-year remission of psoriasis after allogeneic but not autologous bone marrow transplantation. Dermatology. 2006; 212:88–89.
Article
5. Slavin S, Nagler A, Varadi G, Or R. Graft vs autoimmunity following allogeneic non-myeloablative blood stem cell transplantation in a patient with chronic myelogenous leukemia and severe systemic psoriasis and psoriatic polyarthritis. Exp Hematol. 2000; 28:853–857.
Article
6. Kawakami Y, Oyama N, Nakamura K, Kaneko F, Kikuta A, Suzuki H. Psoriasiform eruption associated with graft-versus-host disease. Acta Derm Venereol. 2007; 87:436–438.
Article
7. Matsushita T, Hasegawa M, Shirasaki F, Fujimoto M, Yamazaki H, Sato S, et al. A case of acute cutaneous graft-versus-host disease mimicking psoriasis vulgaris. Dermatology. 2008; 216:64–67.
Article
8. Taguchi S, Kawachi Y, Fujisawa Y, Nakamura Y, Furuta J, Otsuka F. Psoriasiform eruption associated with graft-versus-host disease. Cutis. 2013; 92:151–153.
9. Jordan MB, Filipovich AH. Hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis: a journey of a thousand miles begins with a single (big) step. Bone Marrow Transplant. 2008; 42:433–437.
Article
10. Nickoloff BJ, Wrone-Smith T. Injection of pre-psoriatic skin with CD4+ T cells induces psoriasis. Am J Pathol. 1999; 155:145–158.
Article
11. Zemelman V, Van Neer F, Roberts N, Patel P, Langtry J, Staughton RC. Epidermal Langerhans cells, HIV-1 infection and psoriasis. Br J Dermatol. 1994; 130:307–311.
Article
12. Grabbe S, Steinbrink K, Steinert M, Luger TA, Schwarz T. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity. J Immunol. 1995; 155:4207–4217.
13. Ferrara JL, Deeg HJ. Graft-versus-host disease. N Engl J Med. 1991; 324:667–674.
Article
14. Sanli H, Akay BN, Arat M, Koçyigit P, Akan H, Beksac M, et al. Vitiligo after hematopoietic cell transplantation: six cases and review of the literature. Dermatology. 2008; 216:349–354.
Article
15. Zuo RC, Naik HB, Steinberg SM, Baird K, Mitchell SA, Kuzmina Z, et al. Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease. JAMA Dermatol. 2015; 151:23–32.
Article